DHIL vs VRTX · P/E 9.8, rev $151.1M vs P/E 30, rev $3.33B
Diamond Hill Investment Group Inc (DHIL) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Diamond Hill Investment Group Inc (DHIL) is a asset management company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported DHIL revenue for 2024-12-31 was $151.1M. Net income was $43.2M. Revenue was up 10.5% from 2023-12-31 to 2024-12-31. DHIL currently screens at market cap $473.3M and trailing P/E 9.8.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
DHIL currently screens at market cap $473.3M and trailing P/E 9.8. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the DHIL and VRTX stock pages for the full models.
Not investment advice.